Disorders affecting the motor function of the UPPER ESOPHAGEAL SPHINCTER; LOWER ESOPHAGEAL SPHINCTER; the ESOPHAGUS body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in gastric reflux of food and acid into the esophagus (GASTROESOPHAGEAL REFLUX). Other disorders include hypermotility (spastic disorders) and markedly increased amplitude in contraction (nutcracker esophagus).
Measurement of the pressure or tension of liquids or gases with a manometer.
A hypermotility disorder of the ESOPHAGUS that is characterized by spastic non-peristaltic responses to SWALLOWING; CHEST PAIN; and DYSPHAGIA.
A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus).
The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.
A movement, caused by sequential muscle contraction, that pushes the contents of the intestines or other tubular organs in one direction.
Pathological processes in the ESOPHAGUS.
The act of taking solids and liquids into the GASTROINTESTINAL TRACT through the mouth and throat.
The motor activity of the GASTROINTESTINAL TRACT.
Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.
The physiologic or functional barrier to GASTROESOPHAGEAL REFLUX at the esophagogastric junction. Sphincteric muscles remain tonically contracted during the resting state and form the high-pressure zone separating the lumen of the ESOPHAGUS from that of the STOMACH. (Haubrich et al, Bockus Gastroenterology, 5th ed., pp399, 415)
Analysis of the HYDROGEN ION CONCENTRATION in the lumen of the ESOPHAGUS. It is used to record the pattern, frequency, and duration of GASTROESOPHAGEAL REFLUX.
Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
Contraction of the muscle of the PHARYNX caused by stimulation of sensory receptors on the SOFT PALATE, by psychic stimuli, or systemically by drugs.
The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice.
c-Kit positive cells related to SMOOTH MUSCLE CELLS that are intercalated between the autonomic nerves and the effector smooth muscle cells of the GASTROINTESTINAL TRACT. Different phenotypic classes play roles as pacemakers, mediators of neural inputs, and mechanosensors.
Saccular protrusion beyond the wall of the ESOPHAGUS.
Mobilization of the lower end of the esophagus and plication of the fundus of the stomach around it (fundic wrapping) in the treatment of GASTROESOPHAGEAL REFLUX that may be associated with various disorders, such as hiatal hernia. (From Dorland, 28th ed)
A type of ILEUS, a functional not mechanical obstruction of the INTESTINES. This syndrome is caused by a large number of disorders involving the smooth muscles (MUSCLE, SMOOTH) or the NERVOUS SYSTEM.
Endoscopic examination, therapy or surgery of the esophagus.
Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.
Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.

Altered oesophageal motility following the administration of the 5-HT1 agonist, sumatriptan. (1/117)

BACKGROUND: The 5-HT1 agonist sumatriptan, used in the treatment of migraine, can cause chest pain. AIM: To investigate the effect of a therapeutic dose of sumatriptan (6 mg s.c.) on oesophageal motility. METHODS: In 16 normal healthy subjects aged 19-32 years (9 males), the manometric response of the lower oesophageal sphincter (sleeve sensor), oesophageal body (four sites), stomach and pharynx (to register swallows) to 5 mL water swallows was assessed before and after a subcutaneous injection of either sumatriptan (6 mg) or saline control. Symptoms and ECGs were also monitored. RESULTS: Sumatriptan 6 mg s.c. altered oesophageal motility in all subjects. This was reflected by a significant increase in the amplitude of oesophageal body contractions (change from pre- to 1 h post-injection: sumatriptan 9.9 (2.8, 17.1) mmHg vs. placebo -0.8 (-4.2, 2.6) mmHg, difference 10.8 (4.4, 17.1) mmHg; P=0.003) and a transient increase in lower oesophageal sphincter pressure (change from pre- to 5 min post-injection: sumatriptan 10.9 (5.2, 16.6) mmHg vs. placebo 5.1 (1.8, 8.4) mmHg, difference 5.8 (-0.7, 12.3) mmHg; P=0.08). Sumatriptan had no effect on the velocity of propagation of oesophageal contractions (change from pre- to 1 h post-injection: sumatriptan -0.1 (-0.3, 0.1) cm/s vs. placebo -0.1 (-0.3, 0.0) cm/s, difference 0.1 (-0.1, 0.2) cm/s; P = 0.40). One subject experienced chest symptoms following sumatriptan and, although motility was altered, this did not reach pathological levels. No ECG abnormalities were observed. CONCLUSION: Sumatriptan (6 mg s.c.) significantly alters oesophageal motor function without affecting the ECG. It is therefore possible that sumatriptan-induced chest symptoms may have an oesophageal origin. The evaluation of similar therapeutic agents for migraine on oesophageal function may be justified.  (+info)

Functional esophageal disorders. (2/117)

The functional esophageal disorders include globus, rumination syndrome, and symptoms that typify esophageal diseases (chest pain, heartburn, and dysphagia). Factors responsible for symptom production are poorly understood. The criteria for diagnosis rest not only on compatible symptoms but also on exclusion of structural and metabolic disorders that might mimic the functional disorders. Additionally, a functional diagnosis is precluded by the presence of a pathology-based motor disorder or pathological reflux, defined by evidence of reflux esophagitis or abnormal acid exposure time during ambulatory esophageal pH monitoring. Management is largely empirical, although efficacy of psychopharmacological agents and psychological or behavioral approaches has been established for several of the functional esophageal disorders. As gastroesophageal reflux disease overlaps in presentation with most of these disorders and because symptoms are at least partially provoked by acid reflux events in many patients, antireflux therapy also plays an important role both in diagnosis and management. Further understanding of the fundamental mechanisms responsible for symptoms is a priority for future research efforts, as is the consideration of treatment outcome in a broader sense than reduction in esophageal symptoms alone. Likewise, the value of inclusive rather than restrictive diagnostic criteria that encompass other gastrointestinal and non-gastrointestinal symptoms should be examined to improve the accuracy of symptom-based criteria and reduce the dependence on objective testing.  (+info)

Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors. (3/117)

BACKGROUND: Recent studies from our laboratory reveal that 70% of patients with gastro-oesophageal reflux disease (GERD) on proton pump inhibitors twice daily (b.d.) have nocturnal gastric acid breakthrough (gastric pH < 4 > 1 h) which is often accompanied by oesophageal acid exposure. The pathogenesis of GER during gastric acid breakthrough is not clear. AIM: To determine the prevalence of oesophageal motility abnormalities in patients with nocturnal GER associated with nocturnal acid breakthrough on proton pump inhibitor b.d. METHODS: We reviewed the pH-metry and manometric studies of 100 consecutive patients with GERD who were on proton pump inhibitor b.d. pH tracings were analysed for the nocturnal period (10.00 hours until 06.00 hours). Nocturnal GER was defined as> 0.5% time distal oesophageal pH < 4. Manometric tracings were reviewed for lower oesophageal sphincter (LES) pressure and oesophageal body motility. Chi-squared and Fischer's test were used for statistical analysis. RESULTS: Of the 100 patients, 74 (74%) had nocturnal gastric acid breakthrough. Thirty-one (42%) had concurrent abnormal nocturnal GER (refluxers) and 43 out of 74 (58%) had no GER (non-refluxers). The prevalence of ineffective oesophageal motility, and low LES pressure was significantly higher in refluxers than in non-refluxers (P < 0. 05, P < 0.001, respectively). Ineffective-oesophageal motility has a high specificity (91%), but low sensitivity (45%) as a diagnostic predictor for patients who are more likely to develop nocturnal GER on proton pump inhibitor b.d. CONCLUSION: Ineffective oesophageal motility is a risk factor for proton pump inhibitor refractory GER.  (+info)

Signal transduction in esophageal and LES circular muscle contraction. (4/117)

Contraction of normal esophageal circular muscle (ESO) in response to acetylcholine (ACh) is linked to M2 muscarinic receptors activating at least three intracellular phospholipases, i.e., phosphatidylcholine-specific phospholipase C (PC-PLC), phospholipase D (PLD), and the high molecular weight (85 kDa) cytosolic phospholipase A2 (cPLA2) to induce phosphatidylcholine (PC) metabolism, production of diacylglycerol (DAG) and arachidonic acid (AA), resulting in activation of a protein kinase C (PKC)-dependent pathway. In contrast, lower esophageal sphincter (LES) contraction induced by maximally effective doses of ACh is mediated by muscarinic M3 receptors, linked to pertussis toxin-insensitive GTP-binding proteins of the G(q/11) type. They activate phospholipase C, which hydrolyzes phosphatidylinositol bisphosphate (PIP2), producing inositol 1,4,5-trisphosphate (IP3) and DAG. IP3 causes release of intracellular Ca++ and formation of a Ca++-calmodulin complex, resulting in activation of myosin light chain kinase and contraction through a calmodulin-dependent pathway. Signal transduction pathways responsible for maintenance of LES tone are quite distinct from those activated during contraction in response to maximally effective doses of agonists (e.g., ACh). Resting LES tone is associated with activity of a low molecular weight (approximately 14 kDa) pancreatic-like (group 1) secreted phospholipase A2 (sPLA2) and production of arachidonic acid (AA), which is metabolized to prostaglandins and thromboxanes. These AA metabolites act on receptors linked to G-proteins to induce activation of PI- and PC-specific phospholipases, and production of second messengers. Resting LES tone is associated with submaximal PI hydrolysis resulting in submaximal levels of inositol trisphosphate (IP3-induced Ca++ release, and interaction with DAG to activate PKC. In an animal model of acute esophagitis, acid-induced inflammation alters the contractile pathway of ESO and LES. In LES circular muscle, after induction of experimental esophagitis, basal levels of PI hydrolysis are substantially reduced and intracellular Ca++ stores are functionally damaged, resulting in a reduction of resting tone. The reduction in intracellular Ca++ release causes a switch in the signal transduction pathway mediating contraction in response to ACh. In the normal LES, ACh causes release of Ca++ from intracellular stores and activation of a calmodulin-dependent pathway. After esophagitis, ACh-induced contraction depends on influx of extracellular Ca++, which is insufficient to activate calmodulin, and contraction is mediated by a PKC-dependent pathway. These changes are reproduced in normal LES cells by thapsigargin-induced depletion of Ca++ stores, suggesting that the amount of Ca++ available for release from intracellular stores defines the signal transduction pathway activated by a maximally effective dose of ACh.  (+info)

Vincristine-induced dysphagia suggesting esophageal motor dysfunction: a case report. (5/117)

Transient esophageal motor dysfunction with dysphagia was observed in a 62-year-old man receiving vincristine-containing chemotherapy for non-Hodgkin's lymphoma. Neurological examinations, including muscle strength of extremities, deep tendon reflexes and cranial nerves, were normal. However, the patient complained of severe numbness in the fingertips and toes. The results of esophagogram and esophagoscopy were unremarkable. However, a significantly prolonged esophageal transit time was observed. Vincristine was considered as the causative agent. Empirical vitamin and metoclopramide were prescribed for his neurological symptoms but there was no improvement. The symptoms of dysphagia subsided spontaneously 2 weeks later. However, prompt recurrence of severe dysphagia was observed again after administration of the second and third courses of treatment, which again disappeared upon discontinuation of the drug. Peripheral nerves and the gastrointestinal tract are often affected by vincristine. Common gastrointestinal tract symptoms of vincristine neuropathy may be colicky abdominal pain and constipation. However, vincristine-induced esophageal motor dysfunction with dysphagia is uncommon but generally reversible. The oncologist and chemotherapist should be aware of this complication.  (+info)

Esophagitis-related esophageal shortening in opossum is associated with longitudinal muscle hyperresponsiveness. (6/117)

Acute intraluminal acid perfusion induces esophageal shortening in humans and opossums. Lower esophageal sphincter (LES) hypotension and peristaltic dysfunction occur in patients and animal models of reflux esophagitis. This study examined whether similar shortening and motor dysfunction occur in anesthetized opossums after repeated esophageal acid exposure and whether this is associated with longitudinal muscle (LM) hyperresponsiveness. Manometry used before and after 3 consecutive days of 45-min perfusion with 100 mmol/l HCl or normal saline measured esophageal length and motor responses to induced swallows. LM electrical and mechanical responses were assessed using standard isometric tension and intracellular recording techniques. Compared with controls, repeated acid perfusion induced erosive esophagitis and significant esophageal shortening, associated with enhanced LM responses to carbachol, a significantly depolarized resting membrane potential, and abnormal spike patterns. LES resting pressure and swallow-induced peristalsis were unaffected. In this model of reflux esophagitis, marked persistent esophageal shortening and associated LM hyperresponsiveness occur before significant LES or peristaltic dysfunction, suggesting that esophageal shortening is the earliest motor disorder induced by acid injury.  (+info)

Two cases of severe non-specific oesophageal dysmotility showing different response to botulinum injection therapy. (7/117)

We report 2 cases where treatment of achalasia type symptoms due to severe non-specific oesophageal dysmotility have shown symptom resolution and manometric improvement to intrasphincteric botulinum injections either by itself or in combination with oesophageal dilatation.  (+info)

Effect of graded running on esophageal motility and gastroesophageal reflux in fed volunteers. (8/117)

The effects of different grades of running on esophageal motility and gastroesophageal reflux in the fed state were evaluated. We studied healthy volunteers (male: 12, age: 27 +/- 5 yr) using ambulatory esophageal manometry, pH catheter and portable digital data recorder. Each exercise was performed 30 min after meal, with 20 min of rest between exercises. Subjects exercised on a treadmill at 40% and 70% maximal heart rate. The number of gastroesophageal reflux episodes, the duration of esophageal acid exposure and percent time pH below 4 were significantly (p < 0.01) increased during exercise at 70% maximal heart rate. The frequency of contraction (contraction/min) (p < 0.05), frequency of repetition (p < 0.01), percent of simultaneous contraction (p < 0.01), percent of above 100 mmHg amplitude (p < 0.05), and frequency of 2-peak contraction (p < 0.01) were significantly increased during exercise at 70% maximal heart rate. However, median amplitude and median duration showed no significant changes between each exercise session. Postprandial running exercises induce gastroesophageal reflux, which correlates with exercise intensity. These effects are mediated by disorganized esophageal motility.  (+info)

Esophageal motility disorders are a group of conditions that affect the normal movement (motility) of the muscles in the esophagus, which is the tube that connects the throat to the stomach. The esophageal muscles normally contract and relax in a coordinated manner to help move food from the mouth to the stomach.

In esophageal motility disorders, this muscle movement is impaired, leading to difficulty swallowing (dysphagia), chest pain, heartburn, or regurgitation of food. Some common examples of esophageal motility disorders include:

1. Achalasia: a condition in which the lower esophageal sphincter muscle fails to relax properly, preventing food from passing into the stomach.
2. Diffuse esophageal spasm: a disorder characterized by uncoordinated contractions of the esophageal muscles, leading to difficulty swallowing and chest pain.
3. Nutcracker esophagus: a condition in which the esophageal muscles contract too forcefully, causing pain and difficulty swallowing.
4. Hypertensive lower esophageal sphincter: a disorder in which the lower esophageal sphincter muscle is too tight, making it difficult to swallow and leading to symptoms such as heartburn and regurgitation.
5. Ineffective esophageal motility: a condition in which the esophageal muscles have weak or disorganized contractions, leading to difficulty swallowing and other symptoms.

Esophageal motility disorders can be diagnosed through tests such as manometry, which measures the pressure and coordination of esophageal muscle contractions, or barium swallow studies, which use X-rays to visualize the movement of food through the esophagus. Treatment may include medications, lifestyle changes, or surgery, depending on the specific disorder and its severity.

Manometry is a medical test that measures pressure inside various parts of the gastrointestinal tract. It is often used to help diagnose digestive disorders such as achalasia, gastroparesis, and irritable bowel syndrome. During the test, a thin, flexible tube called a manometer is inserted through the mouth or rectum and into the area being tested. The tube is connected to a machine that measures and records pressure readings. These readings can help doctors identify any abnormalities in muscle function or nerve reflexes within the digestive tract.

Diffuse Esophageal Spasm (DES) is a motility disorder of the esophagus, which is the muscular tube that connects the throat to the stomach. In DES, the esophagus involuntarily and uncoordinately contracts, causing difficulty swallowing (dysphagia), chest pain, and sometimes regurgitation of food or liquids.

The term "diffuse" refers to the fact that these spasms can occur throughout the entire length of the esophagus, rather than being localized to a specific area. The exact cause of diffuse esophageal spasm is not known, but it may be associated with abnormalities in the nerve cells that control muscle contractions in the esophagus.

Diagnosis of DES typically involves a combination of medical history, physical examination, and specialized tests such as esophageal manometry or ambulatory 24-hour pH monitoring. Treatment options may include medications to relax the esophageal muscles, lifestyle modifications such as avoiding trigger foods, and in some cases, surgery.

Esophageal achalasia is a rare disorder of the esophagus, the tube that carries food from the mouth to the stomach. In this condition, the muscles at the lower end of the esophagus fail to relax properly during swallowing, making it difficult for food and liquids to pass into the stomach. This results in symptoms such as difficulty swallowing (dysphagia), regurgitation of food, chest pain, and weight loss. The cause of esophageal achalasia is not fully understood, but it is believed to be related to damage to the nerves that control the muscles of the esophagus. Treatment options include medications to relax the lower esophageal sphincter, botulinum toxin injections, and surgical procedures such as laparoscopic Heller myotomy or peroral endoscopic myotomy (POEM).

The esophagus is the muscular tube that connects the throat (pharynx) to the stomach. It is located in the midline of the neck and chest, passing through the diaphragm to enter the abdomen and join the stomach. The main function of the esophagus is to transport food and liquids from the mouth to the stomach for digestion.

The esophagus has a few distinct parts: the upper esophageal sphincter (a ring of muscle that separates the esophagus from the throat), the middle esophagus, and the lower esophageal sphincter (another ring of muscle that separates the esophagus from the stomach). The lower esophageal sphincter relaxes to allow food and liquids to enter the stomach and then contracts to prevent stomach contents from flowing back into the esophagus.

The walls of the esophagus are made up of several layers, including mucosa (a moist tissue that lines the inside of the tube), submucosa (a layer of connective tissue), muscle (both voluntary and involuntary types), and adventitia (an outer layer of connective tissue).

Common conditions affecting the esophagus include gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal cancer, esophageal strictures, and eosinophilic esophagitis.

Peristalsis is an involuntary muscular movement that occurs in the digestive tract, including the esophagus, stomach, and intestines. It is characterized by alternate contraction and relaxation of the smooth muscles in the walls of these organs, which creates a wave-like motion that helps propel food, fluids, and waste through the digestive system.

The process of peristalsis begins with a narrowing or constriction of the muscle in one area of the digestive tract, followed by a relaxation of the muscle in the adjacent area. This creates a localized contraction that moves along the length of the organ, pushing its contents forward. The wave of contractions continues to move along the digestive tract until it reaches the anus, where waste is eliminated from the body.

Peristalsis plays a crucial role in maintaining proper digestion and absorption of nutrients, as well as in the elimination of waste products from the body. Disorders that affect peristalsis, such as gastrointestinal motility disorders, can lead to symptoms such as abdominal pain, bloating, constipation, or diarrhea.

Esophageal diseases refer to a range of medical conditions that affect the esophagus, which is the muscular tube that connects the throat to the stomach. Here are some common esophageal diseases with their brief definitions:

1. Gastroesophageal reflux disease (GERD): A chronic condition in which stomach acid or bile flows back into the esophagus, causing symptoms such as heartburn, chest pain, and difficulty swallowing.
2. Esophagitis: Inflammation of the esophageal lining, often caused by GERD, infection, or medication.
3. Esophageal stricture: Narrowing of the esophagus due to scarring or inflammation, which can make swallowing difficult.
4. Esophageal cancer: Cancer that forms in the tissues of the esophagus, often as a result of long-term GERD or smoking.
5. Esophageal motility disorders: Disorders that affect the normal movement and function of the esophagus, such as achalasia, diffuse spasm, and nutcracker esophagus.
6. Barrett's esophagus: A condition in which the lining of the lower esophagus changes, increasing the risk of esophageal cancer.
7. Esophageal diverticula: Small pouches that form in the esophageal wall, often causing difficulty swallowing or regurgitation.
8. Eosinophilic esophagitis (EoE): A chronic immune-mediated disorder characterized by inflammation of the esophagus due to an allergic reaction.

These are some of the common esophageal diseases, and their diagnosis and treatment may vary depending on the severity and underlying cause of the condition.

Deglutition is the medical term for swallowing. It refers to the process by which food or liquid is transferred from the mouth to the stomach through a series of coordinated muscle movements and neural responses. The deglutition process involves several stages, including oral preparatory, oral transit, pharyngeal, and esophageal phases, each of which plays a critical role in ensuring safe and efficient swallowing.

Dysphagia is the medical term for difficulty with swallowing, which can result from various underlying conditions such as neurological disorders, structural abnormalities, or muscular weakness. Proper evaluation and management of deglutition disorders are essential to prevent complications such as aspiration pneumonia, malnutrition, and dehydration.

Gastrointestinal motility refers to the coordinated muscular contractions and relaxations that propel food, digestive enzymes, and waste products through the gastrointestinal tract. This process involves the movement of food from the mouth through the esophagus into the stomach, where it is mixed with digestive enzymes and acids to break down food particles.

The contents are then emptied into the small intestine, where nutrients are absorbed, and the remaining waste products are moved into the large intestine for further absorption of water and electrolytes and eventual elimination through the rectum and anus.

Gastrointestinal motility is controlled by a complex interplay between the autonomic nervous system, hormones, and local reflexes. Abnormalities in gastrointestinal motility can lead to various symptoms such as bloating, abdominal pain, nausea, vomiting, diarrhea, or constipation.

Gastroesophageal reflux (GER) is the retrograde movement of stomach contents into the esophagus, which can cause discomfort and symptoms. It occurs when the lower esophageal sphincter (a ring of muscle between the esophagus and stomach) relaxes inappropriately, allowing the acidic or non-acidic gastric contents to flow back into the esophagus.

Gastroesophageal reflux becomes gastroesophageal reflux disease (GERD) when it is more severe, persistent, and/or results in complications such as esophagitis, strictures, or Barrett's esophagus. Common symptoms of GERD include heartburn, regurgitation, chest pain, difficulty swallowing, and chronic cough or hoarseness.

The lower esophageal sphincter (LES) is a specialized ring of muscle located at the junction of the esophagus and stomach. It functions as a physiological valve that regulates the direction of content flow between the esophagus and the stomach. Normally, the LES remains contracted to prevent the reflux of gastric contents into the esophagus, and it relaxes during swallowing to allow food to enter the stomach.

A dysfunctional lower esophageal sphincter may lead to gastroesophageal reflux disease (GERD), where stomach acid frequently backs up into the esophagus, causing symptoms such as heartburn, chest pain, and difficulty swallowing.

Esophageal pH monitoring is a medical test used to measure the acidity (pH level) inside the esophagus. The test involves inserting a thin, flexible tube through the nose and down into the esophagus. The tube contains a sensor that detects changes in pH levels and transmits this information to a recording device worn by the patient.

The test typically lasts for 24 hours, during which time the patient keeps a diary of their activities and symptoms. This information is used to correlate any symptoms with changes in pH levels. The test can help diagnose gastroesophageal reflux disease (GERD) and assess the effectiveness of treatment.

It's important to note that there are some precautions to be taken before and after the test, such as avoiding certain medications that may affect the pH levels or interfere with the test results. Patients should follow their healthcare provider's instructions carefully to ensure accurate results.

Deglutition disorders, also known as swallowing disorders, are conditions that affect the ability to move food or liquids from the mouth to the stomach safely and efficiently. These disorders can occur at any stage of the swallowing process, which includes oral preparation (chewing and manipulating food in the mouth), pharyngeal phase (activating muscles and structures in the throat to move food toward the esophagus), and esophageal phase (relaxing and contracting the esophagus to propel food into the stomach).

Symptoms of deglutition disorders may include coughing or choking during or after eating, difficulty initiating a swallow, food sticking in the throat or chest, regurgitation, unexplained weight loss, and aspiration (inhaling food or liquids into the lungs), which can lead to pneumonia.

Deglutition disorders can be caused by various factors, such as neurological conditions (e.g., stroke, Parkinson's disease, multiple sclerosis), structural abnormalities (e.g., narrowing or blockage of the esophagus), muscle weakness or dysfunction, and cognitive or behavioral issues. Treatment for deglutition disorders may involve dietary modifications, swallowing exercises, medications, or surgical interventions, depending on the underlying cause and severity of the condition.

"Gagging" is a reflexive response to an irritation or stimulation of the back of the throat, which involves involuntary contraction of the muscles at the back of the throat and sometimes accompanied by vomiting. It is a protective mechanism to prevent foreign objects from entering the lungs during swallowing. In a medical context, gagging may also refer to the use of a device or maneuver to temporarily block the upper airway as part of certain medical procedures.

The esophagogastric junction (EGJ) is the region of the gastrointestinal tract where the esophagus (the tube that carries food from the mouth to the stomach) meets the stomach. It serves as a physiological sphincter, which helps control the direction of flow and prevent reflux of gastric contents back into the esophagus. The EGJ is also known as the gastroesophageal junction or cardia.

Interstitial Cells of Cajal (ICCs) are specialized cells found in the walls of the gastrointestinal tract, as well as in other organs such as the urinary and vascular systems. They play a crucial role in regulating the motility of the digestive system by acting as pacemakers and mediators of nerve impulses that control muscle contractions. ICCs have a unique morphology, characterized by numerous extensions and a large number of mitochondria, which allow them to generate electrical signals and communicate with surrounding cells. They are named after Santiago Ramón y Cajal, the Spanish histologist who first described these cells in the late 19th century.

An esophageal diverticulum is a small pouch or sac that forms as a result of a protrusion or herniation of the inner lining (mucosa) of the esophagus through the outer layer of muscle in the wall of the esophagus. Esophageal diverticula can occur in any part of the esophagus, but they are most commonly found in the lower third of the esophagus, near the junction with the stomach.

Esophageal diverticula may be congenital (present at birth) or acquired (develop later in life). Acquired esophageal diverticula are often associated with underlying conditions such as esophageal motility disorders, strictures, or tumors that increase the pressure inside the esophagus and cause the mucosa to bulge out through weakened areas of the esophageal wall.

Symptoms of esophageal diverticula may include difficulty swallowing (dysphagia), regurgitation of undigested food, chest pain, heartburn, and recurrent respiratory infections due to aspiration of food or saliva into the lungs. Treatment options for esophageal diverticula depend on the size and location of the diverticulum, as well as the presence of any underlying conditions. Small asymptomatic diverticula may not require treatment, while larger symptomatic diverticula may be treated with surgical removal or endoscopic repair.

Fundoplication is a surgical procedure in which the upper part of the stomach (the fundus) is wrapped around the lower esophagus and then stitched into place. This procedure strengthens the lower esophageal sphincter, which helps prevent acid reflux from the stomach into the esophagus. It is commonly used to treat gastroesophageal reflux disease (GERD) and paraesophageal hernias.

Intestinal pseudo-obstruction, also known as paralytic ileus or functional obstruction, is a gastrointestinal motility disorder characterized by the absence of mechanical obstruction in the intestines, but with symptoms mimicking a mechanical small bowel obstruction. These symptoms may include abdominal distention, cramping, nausea, vomiting, and constipation or difficulty passing stools.

The condition is caused by impaired intestinal motility due to dysfunction of the nerves or muscles that control the movement of food and waste through the digestive system. It can be a chronic or acute condition and may occur as a primary disorder or secondary to other medical conditions, such as surgery, trauma, infections, metabolic disorders, neurological diseases, or certain medications.

Diagnosis of intestinal pseudo-obstruction typically involves imaging studies, such as X-rays or CT scans, to rule out mechanical obstruction and confirm the presence of dilated bowel loops. Manometry and other specialized tests may also be used to assess intestinal motility. Treatment options include medications to stimulate intestinal motility, dietary modifications, and in severe cases, surgery or intravenous nutrition.

Esophagoscopy is a medical procedure that involves the visual examination of the esophagus, which is the tube that connects the throat to the stomach. This procedure is typically carried out using an esophagogastroduodenoscope (EGD), a flexible tube with a camera and light on the end.

During the procedure, the EGD is inserted through the mouth and down the throat into the esophagus, allowing the medical professional to examine its lining for any abnormalities such as inflammation, ulcers, or tumors. The procedure may also involve taking tissue samples (biopsies) for further examination and testing.

Esophagoscopy is commonly used to diagnose and monitor conditions such as gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal cancer, and other disorders affecting the esophagus. It may also be used to treat certain conditions, such as removing polyps or foreign objects from the esophagus.

Gastroparesis is a gastrointestinal disorder that affects the stomach's normal motility, resulting in the delayed emptying of food from the stomach into the small intestine. The term "gastroparesis" literally means "stomach paralysis," although the stomach doesn't actually become paralyzed in this condition. Instead, the muscles of the stomach wall become weakened or damaged, leading to a decrease in their ability to contract and push food through the digestive tract effectively.

The causes of gastroparesis can vary, but some common reasons include diabetes (both type 1 and type 2), viral infections, surgery involving the vagus nerve (which controls stomach muscle contractions), certain medications (such as narcotics, antidepressants, and high blood pressure drugs), gastroesophageal reflux disease (GERD), scleroderma, Parkinson's disease, multiple sclerosis, and Amyloidosis.

Symptoms of gastroparesis may include nausea, vomiting, feeling full quickly after starting to eat, bloating, heartburn, abdominal pain, lack of appetite, and unintended weight loss. These symptoms can significantly impact a person's quality of life and make it difficult for them to maintain proper nutrition.

Diagnosis typically involves a thorough medical history, physical examination, and various tests such as upper endoscopy, gastric emptying studies (such as the scintigraphy scan), and manometry to assess stomach muscle function. Treatment options may include dietary modifications, medications to stimulate stomach contractions or reduce symptoms like nausea and vomiting, botulinum toxin injections, electrical stimulation of the stomach muscles, or, in severe cases, feeding tubes or surgery.

Gastrointestinal diseases refer to a group of conditions that affect the gastrointestinal (GI) tract, which includes the organs from the mouth to the anus, responsible for food digestion, absorption, and elimination of waste. These diseases can affect any part of the GI tract, causing various symptoms such as abdominal pain, bloating, diarrhea, constipation, nausea, vomiting, and weight loss.

Common gastrointestinal diseases include:

1. Gastroesophageal reflux disease (GERD) - a condition where stomach acid flows back into the esophagus, causing heartburn and other symptoms.
2. Peptic ulcers - sores that develop in the lining of the stomach or duodenum, often caused by bacterial infection or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).
3. Inflammatory bowel disease (IBD) - a group of chronic inflammatory conditions of the intestine, including Crohn's disease and ulcerative colitis.
4. Irritable bowel syndrome (IBS) - a functional gastrointestinal disorder characterized by abdominal pain, bloating, and altered bowel habits.
5. Celiac disease - an autoimmune disorder where the ingestion of gluten leads to damage in the small intestine.
6. Diverticular disease - a condition that affects the colon, causing diverticula (small pouches) to form and potentially become inflamed or infected.
7. Constipation - a common gastrointestinal symptom characterized by infrequent bowel movements, hard stools, and difficulty passing stools.
8. Diarrhea - a common gastrointestinal symptom characterized by loose, watery stools and frequent bowel movements.
9. Food intolerances and allergies - adverse reactions to specific foods or food components that can cause various gastrointestinal symptoms.
10. Gastrointestinal infections - caused by bacteria, viruses, parasites, or fungi that can lead to a range of symptoms, including diarrhea, vomiting, and abdominal pain.

An esophageal motility disorder (EMD) is any medical disorder causing difficulty in swallowing, regurgitation of food and a ... Esophageal disease Esophageal motility study Esophageal spasm GERD Nutcracker esophagus Esophagogastric junction outflow ... esophageal webs, or stricture. Solid-and-liquid dysphagia is due to an esophageal motility disorder (or dysmotility) either in ... Esophageal motility disorder may be a result of CREST syndrome, referring to the five main features: calcinosis, Raynaud ...
Efficient transport by the esophagus requires a coordinated, sequential motility pattern that propels food from above and ... encoded search term (Esophageal Motility Disorders) and Esophageal Motility Disorders What to Read Next on Medscape ... Disorders of esophageal motility are referred to as primary or secondary esophageal motility disorders and categorized ... Esophageal motility disorders. Esophageal motility disorders are not uncommon in gastroenterology. The spectrum of these ...
Esophageal Motility Disorders - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the Merck Manuals - ... Achalasia Achalasia Achalasia is a neurogenic esophageal motility disorder characterized by impaired esophageal peristalsis and ... Diffuse esophageal spasm Diffuse Esophageal Spasm Symptomatic diffuse esophageal spasm is part of a spectrum of motility ... See also Overview of Esophageal and Swallowing Disorders Overview of Esophageal and Swallowing Disorders The swallowing ...
Efficient transport by the esophagus requires a coordinated, sequential motility pattern that propels food from above and ... encoded search term (Esophageal Motility Disorders) and Esophageal Motility Disorders What to Read Next on Medscape ... Disorders of esophageal motility are referred to as primary or secondary esophageal motility disorders and categorized ... Esophageal motility disorders. Esophageal motility disorders are not uncommon in gastroenterology. The spectrum of these ...
Esophageal motility disorders are diseases caused by abnormal esophageal muscle function. ... Esophageal motility disorders are diseases caused by abnormal esophageal muscle function. The muscles in the wall of the ... Further investigation may include an esophageal motility study, which is a procedure to assess the motor or muscle function of ... Treatment options include dietary modification and medications which promote appropriate esophageal muscle function. ...
Esophageal motility disorder is an umbrella term for various disorders that make swallowing and getting food to your stomach ... Home , Services , Gut Conditions , Esophageal Motility Disorder. Esophageal Motility Disorder. Esophageal motility disorder is ... What is esophageal motility disorder?. Esophageal motility disorder, also known as esophageal dysmotility, is a medical ... What causes esophageal motility disorder?. There is not one primary cause for esophageal motility disorder. The causes will be ...
Esophageal Motility Disorders - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - ... Achalasia Achalasia Achalasia is a neurogenic esophageal motility disorder characterized by impaired esophageal peristalsis and ... Diffuse esophageal spasm Diffuse Esophageal Spasm Symptomatic diffuse esophageal spasm is part of a spectrum of motility ... See also Overview of Esophageal and Swallowing Disorders Overview of Esophageal and Swallowing Disorders The swallowing ...
Disorders of Esophageal Contraction (Motility Disorders). Esophageal and Swallowing Disorders. *Gastroesophageal Reflux Disease ... Patients with esophageal motility disorders are then treated, for example in achalasia, they may undergo pneumatic endoscopic ... Esophageal motility disorders cause abnormalities in the contraction mechanism of the esophagus usually manifesting as non- ... The primary motility disorders are achalasia, diffuse esophageal spasm, nutcracker esophagus, and ineffective peristalsis. ...
Use of endoscopic ultrasound in patients with esophageal motility disorders. Gastroenterology Nursing. 1989 Jan 1;12(2):98-99. ... Use of endoscopic ultrasound in patients with esophageal motility disorders. In: Gastroenterology Nursing. 1989 ; Vol. 12, No. ... Use of endoscopic ultrasound in patients with esophageal motility disorders. Maria E. Bertagnolli, Michael Loebenberg, Stanley ... Dive into the research topics of Use of endoscopic ultrasound in patients with esophageal motility disorders. Together they ...
... be followed by a discussion of the diagnostic approach to identify the underlying cause of the esophageal motility disorder, ... will finish with a description of dietary interventions and other ancillary treatments to address esophageal motility disorders ... Participants will then learn a classification scheme for motility disorders of the esophagus, including functional obstruction ... small animal internal medicine with special interests in respiratory medicine and a particular focus on lower airway disorders ...
Gaschen, F. (2015). Disorders of Esophageal, Gastric, and Intestinal Motility in Cats. Augusts Consultations in Feline ...
Esophageal motility disorder *Nutcracker esophagus. *Achalasia. *Esophagogastric junction outflow obstruction. *Diffuse ... chronic intestinal disorders, prior history of repeated disabling bouts of TD, or scenarios in which the onset of diarrhea ...
Esophageal motility disorder *Nutcracker esophagus. *Achalasia. *Esophagogastric junction outflow obstruction. *Diffuse ... Furthermore, biliary pain may be associated with functional disorders of the biliary tract, so-called acalculous biliary pain ( ...
Oesophageal Motility Disorders: Rapid Functional Diagnosis Using Computerised Radionuclide Oesophageal Transit Study ... Oesophageal Motility Disorders: Rapid Functional Diagnosis Using Computerised Radionuclide Oesophageal Transit Study ...
Esophageal motility disorders. 1/1,178 (,0.1). 0. 0. 0. 1/836 (,0.1). ...
285 Results for Esophageal Motility Disorders near Ashburn, VA 20147 Sort: Recommended. Recommended Distance Rating: High to ... Alzheimers diseaseAnemiaArthritisAsthmaAutismBipolar disorderBreast cancerCancerConstipationCOPDCoronavirusCrohns disease ... disordersHeart healthTransgender healthHepatitis CType 2 diabetesInflammationVaccinations and immunizationsLung cancerWeight ... disordersHeart healthTransgender healthHepatitis CType 2 diabetesInflammationVaccinations and immunizationsLung cancerWeight ...
Esophageal spasms are abnormal contractions of the muscles in the esophagus, the tube that carries food from the mouth to the ... Esophageal spasms are abnormal contractions of the muscles in the esophagus, the tube that carries food from the mouth to the ... Esophageal neuromuscular function and motility disorders. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtrans ... Diffuse esophageal spasm; Spasm of the esophagus; Distal esophageal spasm; Nutcracker esophagus ...
Esophageal Diverticulum. *Esophageal Motility Disorders. *Esophageal Ulcer. *Esophageal Varices. *Esophagitis. *Familial ...
... esophageal spasm can be divided into 2 major variants that are distinct entities: (1) diffuse esophageal spasm and (2) ... Diffuse esophageal spasm is characterized by contractions that are of normal amplitude but are uncoordinated, simultaneous, or ... Esophageal bougienage in symptomatic patients with the nutcracker esophagus. A primary esophageal motility disorder. JAMA. 1984 ... Esophageal motility disorders. Floch MH, Kowdley KV, Pitchumoni CS, Floch NR, Rosenthal R, Scolapio J, eds. Netters ...
Esophageal motility disorders. *Research focus on the early detection and treatment of cancerous and pre-cancerous lesions of ... MemberEsophageal Interest Group, Division of Gastroenterology and Hepatology, Department of Internal Medicine ...
60 medical students classified 30 typical examples of a range of motility disorders in both line plots (10 sensors, including a ... Esophageal Motility Disorders / diagnosis* * Evaluation Studies as Topic * Female * Humans * Male * Manometry / methods* ...
Esophageal Motility Disorders ... Alzheimers diseaseAnemiaArthritisAsthmaAutismBipolar disorder ... disordersHeart healthTransgender healthHepatitis CType 2 diabetesInflammationVaccinations and immunizationsLung cancerWeight ... disordersHeart healthTransgender healthHepatitis CType 2 diabetesInflammationVaccinations and immunizationsLung cancerWeight ... disordersStrokeTransgender healthType 1 diabetesType 2 diabetesUlcerative colitisVaccinations and immunizationsWeight ...
It is most often done with other tests to measure esophageal function. Learn more here. ... Esophageal neuromuscular function and motility disorders. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtrans ... Esophageal symptoms and selection of diagnostic tests. In: Yeo CJ, ed. Shacklefords Surgery of the Alimentary Tract. 8th ed. ... A positive test shows that your symptoms are caused by esophageal reflux of acid from the stomach. ...
Other esophageal motility disorders. Effective for esophageal spasm, nut cracker and jackhammer esophagus. Combined ... Full-thickness myotomy is not necessary for treating esophageal achalasia and other esophageal motility disorders, and ... or other mixed esophageal motility disorders, such as diffuse esophageal spasm, nutcracker and jackhammer esophagus[7-9], ... an atlas of esophageal motility disorders and findings of GERD using esophageal pressure topography. Thorac Surg Clin. 2011;21: ...
Esophageal motility study to assess for swallowing disorders using high-resolution manometry and EndoFLIP ... Peroral endoscopic myotomy (POEM) to treat esophageal and gastric motility disorders, as well as Zenkers diverticulum ... Gastrointestinal Disorders We Treat. Our experienced team of digestive health experts treats a wide range of gastric and ... Our resources include the latest advances in the diagnosis and treatment of gastrointestinal disorders, including minimally ...
Associated conditions may include esophageal motility disorders, esophageal spasm, or aspiration. Some authors believe this ... including esophageal motility disorders, esophageal spasm, and aspiration ... Any impairment of the oral phase of deglutition secondary to neuromuscular disorders, trauma, surgical resection, or facial ... 4. In patients with athetoid disorders with constant tongue thrusting, surgical procedures to correct drooling may result in an ...
Esophageal Motility Disorder (12/2021). This may seem very ironic but I am here on behalf of my acupuncturist. She divulged ... Esophageal Motility Disorder (2/2021). I really appreciate the reply. I will inquire further and see if she has done any ...
14 Richter J E. Oesophageal motility disorders. Lancet. 2001; 358 823-828 ... 13 Dogan I, Mittal R K. Esophageal motor disorders: recent advances. Curr Opin Gastroenterol. 2006; 22 417-422 ... 12 Spechler S J, Castell D O. Classification of oesophageal motility abnormalities. Gut. 2001; 49 145-151 ... 5 Katz P O. Intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease. Aliment Pharmacol ...
Esophageal motility disorders, divericula, hiatal hernia, esophagitis 6. Indigestion (dyspepsia), acute and chronic gastritis ... Bleeding disorders due to abnormal or low amounts of clotting factors - hemophilia, disseminated intravascular coagulation (DIC ... Gastroesophageal reflux disease and esophageal tumors 30. Choledocholithiasis, cholangitis, biliary stricture and biliary ... type IV collagen disorders, renal tubular acidosis) 2. Diagnostic tests in nefrology 3. Acute glomerulonephritis and rapidly ...
Esophageal neuromuscular function and motility disorders. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtrans ... Esophageal symptoms and selection of diagnostic tests. In: Yeo CJ, ed. Shackelfords Surgery of the Alimentary Tract. 8th ed. ... A positive test shows that your symptoms are caused by esophageal reflux of acid from the stomach. ... It is most often done with other tests to measure esophageal function. ...

No FAQ available that match "esophageal motility disorders"

No images available that match "esophageal motility disorders"